Pfizer : PFE

All Pfizer Articles

1510 Articles

Douglas A. McIntyre | Oct 1, 2007 at 3:13 AM EDT

Media Digest 10/1/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, UBS (UBS) will write-off $3.4 billion, another victim of the credit crunch. Reuters writes that the Teamsters…

Douglas A. McIntyre | Sep 28, 2007 at 1:11 PM EDT

Pfizer (PFE) Not Up On Viagra

A Canadian court ruled that Apotex could not market a generic version of Viagra, Pfizer’s (PFE) massively successful ED drug.…

Douglas A. McIntyre | Sep 5, 2007 at 5:00 AM EDT

Pfizer: Stay On That Lipitor

Patients who swtich from Pfizer’s (PFE) monster selling drug cholesterol pill Lipitor to Merck’s (MRK) Zocor, now available in generic…

Douglas A. McIntyre | Aug 31, 2007 at 3:31 AM EDT

Media Digest 8/31/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Bush will outline a plan to help holders of sub-prime mortgages. Reuters writes that Dell (DELL) topped…

Douglas A. McIntyre | Aug 28, 2007 at 9:19 AM EDT

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s,…

Douglas A. McIntyre | Aug 28, 2007 at 8:38 AM EDT

Xoma Gets A Boost

Biopharmaceutical company Xoma (XOMA) is having its luck day. After its stock traded down as low as $2.24, its shares…

Douglas A. McIntyre | Aug 7, 2007 at 3:16 AM EDT

Media Digest 8/7/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Bear Stearns (BSC) has several potential buyers including JP Morgan (JPM) and Bank of America (BAC) Reuters…

Douglas A. McIntyre | Aug 6, 2007 at 7:07 PM EDT

PFizer’s (PFE) Promising New HIV Drug

Pfizer (PFE) has FDA approval for a new drug that "blocks the CCR5 co-receptor that serves as a main doorway…

Douglas A. McIntyre | Jul 20, 2007 at 3:27 AM EDT

NYSE Short Interest For July

Below are key short interest statistics for July. The figures are as of July 13 compared to June 15, 2007…

Douglas A. McIntyre | Jul 18, 2007 at 7:15 AM EDT

Pre-Market Stock News (July 18, 2007)

(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items;…

Douglas A. McIntyre | Jul 18, 2007 at 5:59 AM EDT

Pfizer’s (PFE) Bad Hair Day

Not a good quarter for Pfizer (PFE). Second quarter revenue fell 6% to $11.1 billion. Net income was down 48%…

Douglas A. McIntyre | Jul 13, 2007 at 4:58 PM EDT

Top Earnings Next Week Part 1 (July 16-18, 2007)

MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch (NYSE:MER)Novartis (NYSE:NVS/ADR)Pharmaceutical Product Development (NASDAQ:PPDI)SLM…

Douglas A. McIntyre | Jun 24, 2007 at 12:16 PM EDT

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a…

Douglas A. McIntyre | Jun 22, 2007 at 8:41 AM EDT

DJIA Components Short Interest Mixed (June 2007)

Stock Tickers: AA, AIG, AXP, BA, C, CAT, DD, DIS, GE, GM, HD, HON, HPQ, IBK, JNJ, JPM, KO, MCD,…

Douglas A. McIntyre | Jun 22, 2007 at 3:16 AM EDT

Media Digest 6/22/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, the IPO for Blackstone priced at the high end of its range, raising $4.13 billion. Reuters writes…

1 … 98 99 100 101

Pfizer : PFE

All Pfizer Articles

Media Digest 10/1/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Pfizer (PFE) Not Up On Viagra

Pfizer: Stay On That Lipitor

Media Digest 8/31/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

Xoma Gets A Boost

Media Digest 8/7/2007 Reuters, WSJ, NYTimes, FT, Barron’s

PFizer’s (PFE) Promising New HIV Drug

NYSE Short Interest For July

Pre-Market Stock News (July 18, 2007)

Pfizer’s (PFE) Bad Hair Day

Top Earnings Next Week Part 1 (July 16-18, 2007)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

DJIA Components Short Interest Mixed (June 2007)

Media Digest 6/22/2007 Reuters, WSJ, NYTimes, FT, Barron’s

He Retired at 55 With $1.2 Million in His 401(k). One Routine Paperwork Move Would Have Locked It All Up for Years

Have a Big 401(k) and Turning 60? Your Catch-Up Limit Just Jumped to $11,250 and the Window Closes at 64

Chief Economic Adviser: “There Is No Way” the Bond Market Can Fund the AI Boom Without Higher Yields

He Retired at 55 With $1.2 Million in His 401(k). One Routine Paperwork Move Would Have Locked It All Up for Years

Have a Big 401(k) and Turning 60? Your Catch-Up Limit Just Jumped to $11,250 and the Window Closes at 64

He Retired at 55 With $1.2 Million in His 401(k). One Routine Paperwork Move Would Have Locked It All Up for Years

Have a Big 401(k) and Turning 60? Your Catch-Up Limit Just Jumped to $11,250 and the Window Closes at 64

Pfizer : PFE

All Pfizer Articles

Media Digest 10/1/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Pfizer (PFE) Not Up On Viagra

Pfizer: Stay On That Lipitor

Media Digest 8/31/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

Xoma Gets A Boost

Media Digest 8/7/2007 Reuters, WSJ, NYTimes, FT, Barron’s

PFizer’s (PFE) Promising New HIV Drug

NYSE Short Interest For July

Pre-Market Stock News (July 18, 2007)

Pfizer’s (PFE) Bad Hair Day

Top Earnings Next Week Part 1 (July 16-18, 2007)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

DJIA Components Short Interest Mixed (June 2007)

Media Digest 6/22/2007 Reuters, WSJ, NYTimes, FT, Barron’s

He Retired at 55 With $1.2 Million in His 401(k). One Routine Paperwork Move Would Have Locked It All Up for Years

Have a Big 401(k) and Turning 60? Your Catch-Up Limit Just Jumped to $11,250 and the Window Closes at 64

Chief Economic Adviser: “There Is No Way” the Bond Market Can Fund the AI Boom Without Higher Yields

Featured Reads

He Retired at 55 With $1.2 Million in His 401(k). One Routine Paperwork Move Would Have Locked It All Up for Years

Have a Big 401(k) and Turning 60? Your Catch-Up Limit Just Jumped to $11,250 and the Window Closes at 64